2009 Press Releases
MMI Clinician Scientist Fellowship Programme Annual Meeting
17.07.2009
The first Molecular Medicine Ireland (MMI) Clinician Scientist Fellowship Programme (CSFP) Annual Meeting took place earlier this month at NUI Galway.
17.07.2009
The first Molecular Medicine Ireland (MMI) Clinician Scientist Fellowship Programme (CSFP) Annual Meeting took place earlier this month at NUI Galway.
Molecular Medicine Ireland is a not for profit company established by National University of Ireland Galway, Royal College of Surgeons in Ireland, Trinity College Dublin, University College Cork and University College Dublin to achieve their common objectives in accelerating the translation of scientific research into better quality outcomes for patients.
The objective of the CSFP is to train the next generation of clinician scientists with the unique and specialised knowledge essential to fulfil Ireland’s research needs in translational medicine. The CSFP is funded by the Irish Government under the Programme for Research in Third Level Institutions, cycle 4. Fellows from five institutions including UCC, who have a shared agenda in clinical and translational research are participating in the Programme, which is being coordinated by Molecular Medicine Ireland.
This training programme transcends institutional boundaries and provides systematic training for this group of clinician researchers through a structured PhD programme. Twenty two MMI Fellows have been appointed to date.
The CSFP Annual Meeting gathered key individuals involved in this MMI programme, including the Fellows’ supervisors. A highlight of the day was the Keynote Lecture delivered by Professor Sherine Gabriel (William J. and Charles H. Mayo Professor of Medicine and Epidemiology, Mayo Clinic, MN, US), the title of which was ‘Heart Disease and Premature Death in Rheumatoid Arthritis: Lessons from Epidemiology’.
"Today is a milestone in the Clinician Scientist Fellowship programme" commented Dr Ruth Barrington, CEO of MMI. "The research presented by the Fellows is at the cutting edge of science and is of great significance for more effective diagnosis of disease and treatment of patients. The Fellows are contributing to Ireland’s reputation for excellence in clinical and translational research. They are also making Ireland a more attractive place for investment by healthcare industries in research and development", she said.
Picture shows: Dr Geraldine Boylan (UCC) and Dr Ruth Barrington (MMI) pictured with MMI Clinician Scientist Fellows from UCC: Dr Brian Walsh, Dr Fergus McCarthy, Dr Daniel Schmidt and Dr John O’Sullivan.
1177MMcS
The objective of the CSFP is to train the next generation of clinician scientists with the unique and specialised knowledge essential to fulfil Ireland’s research needs in translational medicine. The CSFP is funded by the Irish Government under the Programme for Research in Third Level Institutions, cycle 4. Fellows from five institutions including UCC, who have a shared agenda in clinical and translational research are participating in the Programme, which is being coordinated by Molecular Medicine Ireland.
This training programme transcends institutional boundaries and provides systematic training for this group of clinician researchers through a structured PhD programme. Twenty two MMI Fellows have been appointed to date.
The CSFP Annual Meeting gathered key individuals involved in this MMI programme, including the Fellows’ supervisors. A highlight of the day was the Keynote Lecture delivered by Professor Sherine Gabriel (William J. and Charles H. Mayo Professor of Medicine and Epidemiology, Mayo Clinic, MN, US), the title of which was ‘Heart Disease and Premature Death in Rheumatoid Arthritis: Lessons from Epidemiology’.
"Today is a milestone in the Clinician Scientist Fellowship programme" commented Dr Ruth Barrington, CEO of MMI. "The research presented by the Fellows is at the cutting edge of science and is of great significance for more effective diagnosis of disease and treatment of patients. The Fellows are contributing to Ireland’s reputation for excellence in clinical and translational research. They are also making Ireland a more attractive place for investment by healthcare industries in research and development", she said.
Picture shows: Dr Geraldine Boylan (UCC) and Dr Ruth Barrington (MMI) pictured with MMI Clinician Scientist Fellows from UCC: Dr Brian Walsh, Dr Fergus McCarthy, Dr Daniel Schmidt and Dr John O’Sullivan.
1177MMcS